Coding jobs are thought to be under threat amid the AI wave, but it appears that code itself could end up becoming ...

Agent Interoperability Will Unlock the Next Wave of AI Productivity. For a while now, AI agents have been like isolated ...

On SWE-Bench Verified, the model achieved a score of 70.6%. This performance is notably competitive when placed alongside significantly larger models; it outpaces DeepSeek-V3.2, which scores 70.2%, ...

While there has been much talk about the artificial-intelligence trade becoming overhyped, Bank of America believes “peak optimism” is still ahead of us. For the past two years, the AI sector has been ...

Head 2 Head: AMD's chips have powered nearly all handheld gaming PCs over the past few years, but Intel has pledged to challenge the company in the emerging segment in 2026. Intel argues that its ...

At CES 2026, Archer Aviation Inc. (NYSE: ACHR) announced plans to develop and deploy the next generation of artificial intelligence technologies for aviation using the NVIDIA IGX Thor platform. This ...

If you've been thinking about taking a cruise, you may want to book it now – or at least within the next couple of months. Wave season, the annual period when cruise lines run a wide range of deals, ...

D-Wave Quantum is among the few companies successfully commercializing quantum annealing technology. The company’s Advantage2 platform is gaining commercial traction. With more than 100 ...

It was a banner year for horror, which not only dominated commercial markets but also broke through the awards barrier. The Oscars shortlist highlighted the genre’s critical success by recognizing ...

The hydropower industry stands at a critical juncture where traditional operation and maintenance are quickly becoming obsolete. As global energy demand surges and grid systems become increasingly ...

D-Wave has seen incredible valuation gains in conjunction with rising interest in quantum computing. The company has been posting encouraging sales growth, but trades at a highly growth-dependent ...

GSK has been impressing me with strong revenue and EPS numbers for the eighth quarter in a row. Also, on December 12, depemokimab, GSK's anti-IL-5 antibody with 6-month dosing, received a positive EMA ...